2026 Semifinalists

2026

President’s Innovation Challenge

Out of 400+ applications, we've selected 180+ PIC semifinalists. These ventures represent all 13 Harvard schools and are one step closer to winning a share of $500,000+ in Bertarelli Foundation funding.

pic finalist gif

An internal PIC selection committee reviews initial venture applications and selects the semifinalists.

Industry

Program

School

Clear all filters

Absco Therapeutics

AbscoTx injects image-guided therapy into tumors to educate the immune system to fight cancer locally and at metastatic sites.
Linton Lifesciences

Using 3D bioprinting to create custom arteries for bypass surgery, aiming to replace traditional autologous grafts.
NuCyRNA Therapeutics

Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
PathCision Medicine

Developing tissue-informed precision therapeutics with superior delivery and efficacy for cancer and other complex diseases.